38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
1	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely dipyridamole 75 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tramadol hydrochloride 300 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely loracarbef 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nisoldipine 20 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lamotrigine 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely montelukast sodium 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phentermine hydrochloride 18.75 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thiamazole 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely propranolol hydrochloride 80 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nabilone 2 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely meclozine hydrochloride 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oxypertine 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Phenazopyridine 100mg tablets	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely encainide hydrochloride 25 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely spironolactone 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely perphenazine 16 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 750 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely diphenhydramine hydrochloride 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenofibrate micronized 43 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naltrexone hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fosinopril sodium 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sulfamethoxazole 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thioridazine hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tiagabine 15 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mesoridazine besilate 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely maprotiline hydrochloride 75 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely omeprazole (as omeprazole magnesium) 20 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prochlorperazine 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mirtazapine 15 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trimipramine maleate 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pindolol 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely rifapentine 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely progesterone 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oxypertine 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oxacillin sodium 500 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methylphenidate hydrochloride 50 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phenazopyridine hydrochloride 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely valproate sodium 200 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely propylthiouracil 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naltrexone hydrochloride 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydralazine hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thioridazine hydrochloride 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ketorolac 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mesoridazine besilate 25 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenofibrate 48 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 800 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen 250 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lacosamide 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prochlorperazine 15 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely venlafaxine hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methyltestosterone 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolbutamide 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely flucytosine 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely labetalol hydrochloride 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 2.5 milligram/1 each conventional release oromucosal lozenge	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pregabalin 150 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ofloxacin 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 10 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydromorphone hydrochloride 2 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely maraviroc 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nicorandil 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenofibrate micronized 87 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phentermine hydrochloride 37.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phenylbutazone 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely rabeprazole sodium 10 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thioridazine hydrochloride 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium fluoride 1.1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier

Start Previous Page 53 of 342 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442105014	1	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module